UnitedHealth's stock surged over 8% following a Medicare payment update that increased payments to private insurers by 2.48%, exceeding market expectations. HSBC upgraded the stock to "Hold" with a $300 target, while Bank of America raised its price target to $337 but kept a "Neutral" rating. Bernstein also raised its target to $411 and maintained an "Outperform" rating, citing margin improvements and faster Medicare Advantage recovery. Analysts see strong upside potential, with an average 12-month price target of $465.95, suggesting a 33.57% gain ahead.
Piper Sandler raised its price target for UnitedHealth Group to $475, suggesting a 13.3% upside from its current price of $419.23. The company, the largest U.S. health insurer, has consistently beaten earnings estimates, with its latest EPS of $7.23 ...
The SCHD ETF has returned just under 2% in the past month, outperforming the S&P 500 ETF (SPY) by nearly 1%. Year-to-date, about 30 SCHD holdings have more than doubled the returns of SPY, which has returned 9.8%. Additionally, 31 SCHD holdings are t...
Elevance Health and UnitedHealth Group, two of the largest U.S. health insurers, are set to report their second-quarter earnings this week. Investors and analysts are watching closely to see if these companies have maintained control over rising medi...
